ConCallIQ
Go Pro
METROPOLISHEALTHCARE Healthcare 15 May 2026

Metropolis Healthcare Ltd — Q4 FY26

Metropolis Healthcare delivered a strong FY26 with group revenue of ₹1,646 crore (+23.6% YoY) and EBITDA margin of 24.4%.

bullish high
Compare with...
Revenue ₹425 Cr +23.6%
EBITDA ₹401 Cr +32%
PAT ₹51 Cr +31%
EBITDA Margin 25%
Duration 55 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Competitive intensity in tier-1 cities

Growth in tier-1 cities like Mumbai is around 11-14%, potentially constrained by high competition from organized and unorganized players.

medium · analyst_question
R

Integration risks from future M&A

While current acquisitions are on track, future deals may face quality and integration challenges, as management noted many assets do not meet their standards.

medium · management_commentary
R

Dependence on price increases for growth

Management indicated no price hike planned currently, but realization growth partly relies on future price increases, which may not materialize if competitive pressures persist.

low · data_observation